| PDF (152kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-268543
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.26854
Alternative Links zum Volltext:Pubmed
Zusammenfassung
Ketanserin, which preferentially blocks 5-HT2-serotonergic receptors, was injected intravenously (i.v.) to patients with congestive heart failure in a bolus dose of 10 mg, followed by an i.v. infusion of 3 mg/h over a period of 4 h. The drug caused a decrease in total peripheral resistance and, conversely, an increase in stroke volume. Right atrial and pulmonary artery pressures were decreased. ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik